I was honoured this week to be invited to visit Abbott headquarters in Minneapolis to meet the TAVR/Structural heart team over 2 days. Meeting the US leadership team, listening to multiple presentations from R&D team, clinical researchers & engineers who works on designing,

Abdel Almanfi, MD, FACC, FSCAI Congratulations Abdel Almanfi, MD, FACC, FSCAI on all ur work and achievements

Rafael Leao almost walked this goal in 💪

I enjoyed participating and presenting at The (TAVR Summit 2024) in Dallas Texas. My presentation was on the Role of Artificial Intelligence AI in TAVR, also discussing the lessons learned from SMART trial. Great attendance, wonderful debates with very challenging cases.

Moderate Aortic Stenosis is not as 'benign' entity as many thinks, especially with LV dysfunction.
-------------
Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered? cardiovascularbusiness.com/topics/clinica…

Dr Shariq Shamim Abdel Almanfi, MD, FACC, FSCAI Mohamad Alkhouli I would rather it took care of note writing, billing, and straightforward inbox activities and left human beings more time to perform the thoughtful components of peer review .

Abdel Almanfi, MD, FACC, FSCAI Mohamad Alkhouli Exactly. Earlier we adopt it, easier it would be for everyone. As they say, we can’t stop an idea whose time has come.

Abdel Almanfi, MD, FACC, FSCAI SCAI_Prez @SCAI James Hermiller George Dangas, MD, MACC, MSCAI Thanks Abdel Almanfi, MD, FACC, FSCAI. Congratulations to you as well! Glad to hear that you will also be on the council, looking forward to working along with you!

Why should you consider becoming a SCAI Mentor?
✅ Share your career story
✅ Give back to the #InterventionalCardiology community
✅ Practice #leadership skills
Mentor Connect is open to all SCAI members.
➡️Learn more and sign up: scai.org/MentorConnect

Sometimes a case by case learning with little critical thinking & curiosity gives you more lessons than an anticipated multi-million dollar clinical trial that need 10 years to complete.

Looking back at my archive
It looks like we were telling people here that Impella save lives in STEMI/shock patients ..
apparently, turned out the “parachute” 🪂 does work

May this day bring the brightest colors of love, laughter, and happiness to your life.
On this special day, I wish you and your loved ones a very happy Eid! #EidMubarak

Usual care doesn’t usually work!
We gotta be aggressive with number one killer worldwide.

Another positive clinical trial in Low risk patients supporting #TAVR first option
———————

Another Early Win for TAVI in Low-Risk Patients | New England Journal of Medicine nejm.org/doi/full/10.10…

Another positive clinical trial for interventional cardiology!

Yes I am very happy & excited for the interventional & structural field
Big winners at ACC 2024 are Evolut TAVR valve & Impella for shock. Little disappointed that almost all medical therapy (bills) trials were negative. 😳

Great study showing the fact we know long time ago, small valves are bad!
SEV Evolut showing superior performance in hemodynamics over BE S3 valve in small annuli patients especially women.